Individual mouse alpha-fetoprotein enhancer elements exhibit different patterns of tissue-specific and hepatic position-dependent activities.

Molecular and Cellular Biology
T RameshB T Spear

Abstract

Transcription of the mouse alpha-fetoprotein (AFP) gene, which is expressed at high levels in the visceral endoderm of the yolk sac and fetal liver and at low levels in the fetal gut, is regulated by three distinct upstream enhancer regions. To investigate the activities of these regions, each enhancer was individually linked to a heterologous human beta-globin promoter fused to the mouse class I H-2Dd structural gene. When tested in transgenic mice, the beta-globin promoter alone has minimal activity. We find that all three enhancers activate the beta-globin promoter in an AFP-like pattern; i.e., activity is detected in the yolk sac, fetal liver, and fetal gut. The enhancers remain active in the livers and guts of adult mice, consistent with previous studies showing that postnatal AFP repression is due not to the loss of enhancer activity but to a dominant repressor region. Enhancer III also functions in the brain. In addition, these studies reveal that the three enhancers exhibit different position-dependent activities in the adult liver. Enhancers I and II are most active in hepatocytes surrounding the central vein, with a gradual decrease in activity along the hepatic plates toward the portal triad. Enhancer III is active e...Continue Reading

References

Sep 1, 1992·Developmental Dynamics : an Official Publication of the American Association of Anatomists·J A EmersonA L Tyner
Sep 24, 1992·Biochimica Et Biophysica Acta·V De Simone, R Cortese
Mar 1, 1992·The Journal of Nutrition·N R Katz
Dec 1, 1991·Current Opinion in Cell Biology·V De Simone, R Cortese
Apr 1, 1990·The Journal of Cell Biology·A L TynerS M Tilghman
Mar 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J J CaterinaT M Townes
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·K G XanthopoulosJ E Darnell
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·S G Widen, J Papaconstantinou
Aug 1, 1988·Genes & Development·R Godbout, S M Tilghman
Apr 1, 1989·Genes & Development·S A Camper, S M Tilghman
Oct 1, 1989·Molecular and Cellular Biology·M H FeuermanS M Tilghman
Jan 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J J Gumucio
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·R R BehringerT M Townes
Nov 1, 1982·Molecular and Cellular Biology·A Belayew, S M Tilghman
Jun 1, 1980·European Journal of Biochemistry·C Auffray, F Rougeon

❮ Previous
Next ❯

Citations

Dec 27, 1996·Annals of the New York Academy of Sciences·V NilakantanH P Glauert
May 19, 2006·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Gloria S KwonMargaret H Baron
Mar 30, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·V M ChristoffelsW H Lamers
May 1, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Erica L ClinkenbeardBrett T Spear
Sep 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·D K PeytonB T Spear
Sep 28, 2000·The Journal of Biological Chemistry·V M ChristoffelsW H Lamers
Apr 15, 1999·Seminars in Cancer Biology·B T Spear
Sep 11, 2002·Toxicology in Vitro : an International Journal Published in Association with BIBRA·M PaparellaS Bremer
Dec 20, 2002·Mechanisms of Development·Nelson Fausto, Jean S Campbell

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.